Article citationsMore >>

Ropper AH. The guillain-Barré syndrome. N Engl J Med. 1992; 326(17): 1130-6.

has been cited by the following article:

Article

Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome as Complications of Coronavirus Disease-2019

1Chicago College of Osteopathic Medicine, Downers Grove, USA

2Department of Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, USA

3Department of Neurology, Advocate Lutheran General Hospital, Park Ridge, USA


American Journal of Medical Case Reports. 2021, Vol. 9 No. 12, 686-689
DOI: 10.12691/ajmcr-9-12-6
Copyright © 2021 Science and Education Publishing

Cite this paper:
Mada Hamwi, Sufyan Abdul Mujeeb, Abdallah Hamdallah. Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome as Complications of Coronavirus Disease-2019. American Journal of Medical Case Reports. 2021; 9(12):686-689. doi: 10.12691/ajmcr-9-12-6.

Correspondence to: Mada  Hamwi, Chicago College of Osteopathic Medicine, Downers Grove, USA. Email: mhamwi91@midwestern.edu

Abstract

Guillain-Barre syndrome (GBS) is a rare inflammatory disorder that most commonly occurs as a response to a preceding infection. Although GBS is most commonly associated with Campylobacter jejuni infection, several reports have indicated a relationship between the novel coronavirus disease-2019 (COVID-19) and GBS. Here, we present a case of a 72-year-old female diagnosed with COVID-19 who developed progressive lower and upper extremity weakness one month following her COVID-19 diagnosis. Magnetic resonance imaging (MRI) of the spine confirmed the diagnosis of GBS and her hospital course was further complicated by posterior reversible encephalopathy syndrome (PRES). She responded well to intravenous immunoglobulin (IVIG) and subacute inpatient rehabilitation.

Keywords